Followers | 237 |
Posts | 10817 |
Boards Moderated | 0 |
Alias Born | 07/17/2006 |
Thursday, May 27, 2021 8:40:56 AM
Wow..Thanks for posting this presentation..And I hope you are good health..
This is technical as well as clinical information and may (will) be difficult to comprehend as it is for me and I have a strong background in both medicine (Harvard Med School) and technology (MIT)..
The crux here is Bionano's technology is not only groundbreaking...it casts a wide sweeping ground breaking effect in genome biology (and clinical medicine) which is comparable to the invention of the microscope in infectious disease and malignancies..But the Saphyr system offers much more than the microscope.
DNA is like a novel and if chapters or paragraphs are out of place the novel becomes unreadable or leads to distortions which lead to birth defects, neurological conditions, and malignancies..What the Saphyr system does is to identify these structural mistakes in the gene sequences: and offers the possibility of correcting these errors.
Bionano's technology is not some minor effect. We are talking about life changing possibilities in conditions like autism or Asperger's or gender problems...And offer a chance to treat hematological malignancies (leukemia and lymphoma and solid tumor malignancies ranging from breast cancer to brain tumors like glioblastoma which are universally fatal).
And for those of us who are interested in the financial details..Bionano prospects appear to be stellar in that aspect also..
A real winner on many levels...
":>) JL
Recent BNGO News
- Bionano Announces up to $30 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules • GlobeNewswire Inc. • 07/05/2024 12:00:00 PM
- Bionano Announces Presentation of OGM Utility Across Stem Cell Therapy Applications at the International Society for Stem Cell Research (ISSCR) Annual Meeting • GlobeNewswire Inc. • 07/02/2024 12:00:00 PM
- Bionano Announces Software Marketing Agreement with Revvity for Newborn Sequencing Research • GlobeNewswire Inc. • 06/20/2024 12:00:00 PM
- Bionano Laboratories Announces New Category I CPT Code for OGM Use in Hematological Malignancy Analysis • GlobeNewswire Inc. • 06/17/2024 08:05:00 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 06/10/2024 09:12:01 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/05/2024 09:49:36 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/05/2024 09:48:08 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/05/2024 09:43:39 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/05/2024 09:42:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/05/2024 09:40:14 PM
- Form D - Notice of Exempt Offering of Securities • Edgar (US Regulatory) • 06/05/2024 06:59:46 PM
- Bionano Announces Robust Presence at Upcoming Cytogenetics Conferences ESHG and ACC with 39 Scientific Presentations and Posters Highlighting the Utility of the Optical Genome Mapping Workflow • GlobeNewswire Inc. • 05/30/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/28/2024 12:15:32 PM
- Bionano Announces Private Placement of Senior Secured Notes in Debt Restructuring that Improves Balance Sheet • GlobeNewswire Inc. • 05/28/2024 12:00:00 PM
- Bionano Announces Three Publications Demonstrating OGM’s Utility for Cell and Gene Therapy • GlobeNewswire Inc. • 05/21/2024 12:00:00 PM
- Bionano Announces Series of Major Advancements to its Suite of Computational Tools for Comprehensive Cancer Analysis • GlobeNewswire Inc. • 05/09/2024 12:00:00 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 05/08/2024 09:27:34 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/08/2024 08:09:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/08/2024 08:02:28 PM
- Bionano Reports First Quarter 2024 Results and Highlights Recent Business Progress • GlobeNewswire Inc. • 05/08/2024 08:01:00 PM
- Bionano to Report First Quarter 2024 Financial Results and Host a Conference Call and Webcast on May 8, 2024 • GlobeNewswire Inc. • 05/01/2024 12:00:00 PM
- Bionano to Present at the RBC Capital Markets 2024 Global Healthcare Conference • GlobeNewswire Inc. • 04/30/2024 08:05:00 PM
- Bionano Announces Publication Showing OGM’s High Resolution Structural Variation Detection in Cancer Validated by Cas9-Directed Nanopore Sequencing • GlobeNewswire Inc. • 04/24/2024 12:00:00 PM
- Bionano and Diagens Sign Partnership to Commercialize the First Ever Clinical Cytogenetic Analysis that Combines OGM and Artificial Intelligence • GlobeNewswire Inc. • 04/17/2024 12:00:00 PM
- Bionano Announces Publication Showing that OGM Detects Over 1250 Structural Variants, including 56 Gene Fusions, in Pediatric Leukemia that were Missed by Whole Genome Sequencing • GlobeNewswire Inc. • 04/11/2024 12:00:00 PM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM